ACTH-derived peptide studied in nootropic, neuroprotective, and stroke-model literature.
What it is
ACTH-derived peptide studied in nootropic, neuroprotective, and stroke-model literature.
Also known as
ACTH(4-10) analog Met-Glu-His-Phe-Pro-Gly-Pro · Semax
Overview
Semax is a synthetic ACTH-fragment analog developed in Russian research programs and studied for nootropic, neuroprotective, and stroke-model endpoints. Literature examines BDNF-related and cognitive-task markers.
It is a reference cognitive-class peptide on many research-supply lists. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
Nootropic and cognitive-task endpoints in research models
• Neuroprotection markers in ischemic/stroke designs
• BDNF and neurotrophic signaling readouts where studied
• Stress and attention-related behavioral markers
• ACTH-fragment analog pharmacology versus related peptides
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early signaling and behavioral endpoints in acute neuro models; exposure establishing.
Week 3–4: Clearer cognitive, stress, or neuroprotective markers in short research windows.
Month 2–3: More stable memory, focus, or neuroplasticity-related endpoints in extended designs.
Month 3–6: Sustained neuro and aging-adjacent observations where longer protocols are used.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.